Cargando…
Archazolid and apicularen: Novel specific V-ATPase inhibitors
BACKGROUND: V-ATPases constitute a ubiquitous family of heteromultimeric, proton translocating proteins. According to their localization in a multitude of eukaryotic membranes, they energize many different transport processes. Since their malfunction is correlated with various diseases in humans, th...
Autores principales: | Huss, Markus, Sasse, Florenz, Kunze, Brigitte, Jansen, Rolf, Steinmetz, Heinrich, Ingenhorst, Gudrun, Zeeck, Axel, Wieczorek, Helmut |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1190152/ https://www.ncbi.nlm.nih.gov/pubmed/16080788 http://dx.doi.org/10.1186/1471-2091-6-13 |
Ejemplares similares
-
Anti-leukemic effects of the V-ATPase inhibitor Archazolid A
por: Zhang, Siwei, et al.
Publicado: (2015) -
The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen
por: Luong, Betty, et al.
Publicado: (2018) -
Identification of myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay
por: Martinez, Javier P, et al.
Publicado: (2013) -
Suzuki coupling-based synthesis of VATPase inhibitor archazolid natural product derived fragments
por: Vincent, Cooper T., et al.
Publicado: (2019) -
Total syntheses of the archazolids: an emerging class of novel anticancer drugs
por: Scheeff, Stephan, et al.
Publicado: (2017)